In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses treatment options for chronic kidney disease patients with ...
“Elevated leukocyte counts, particularly increased neutrophil counts, and decreased hemoglobin levels, are associated with severe WMHs,” according to Dr Liu’s team. “Our study results highlight the ...
Investigators assessed sex differences in the risk for major cardiovascular events (MACE+) among patients with anemia of non-dialysis chronic kidney disease (CKD).
Modus Therapeutics Holding AB ("Modus Therapeutics") hereby publishes an interim report for the third quarter of 2025. The report is available on the company's website ...
Modus Therapeutics Holding AB (“Modus Therapeutics”) hereby publishes an interim report for the third quarter of 2025. The report is available on the company’s website ( and as an attachment to this ...
When the kidneys start to fail, their effects are felt on the internal system of the body. With the gradual decline in ...
Kidney disease disproportionately affects Black communities, with Black Americans nearly four times as likely to develop ...
Akebia Therapeutics has scrapped plans for a trial that would have potentially led to an expansion of the patient population for its new anemia drug Vafseo, the company said. In March 2024, the FDA ...
A study was conducted to determine the relationship between the severity of preprocedural anemia and outcomes following TAVR.
CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...
The global renal anemia market is experiencing significant growth, driven by advancements in therapeutic options, increased diagnostic accuracy, and enhanced healthcare investments in the U.S., Europe ...
Q3 2025 net product revenues grew to $14.3 million; Q3 2025 total net product revenues were $56.8 millionOperational pilot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results